Quantification and Kinetic Analysis of Grb2-EGFR Interaction on Micro-Patterned Surfaces for the Characterization of EGFR-Modulating Substances

The identification of the epidermal growth factor receptor (EGFR) as an oncogene has led to the development of several anticancer therapeutics directed against this receptor tyrosine kinase. However, drug resistance and low efficacy remain a severe challenge, and have led to a demand for novel systems for an efficient identification and characterization of new substances. Here we report on a technique which combines micro-patterned surfaces and total internal reflection fluorescence (TIRF) microscopy (μ-patterning assay) for the quantitative analysis of EGFR activity. It does not simply measure the phosphorylation of the receptor, but instead quantifies the interaction of the key signal transmitting protein Grb2 (growth factor receptor-bound protein 2) with the EGFR in a live cell context. It was possible to demonstrate an EGF dependent recruitment of Grb2 to the EGFR, which was significantly inhibited in the presence of clinically tested EGFR inhibitors, including small tyrosine kinase inhibitors and monoclonal antibodies targeting the EGF binding site. Importantly, in addition to its potential use as a screening tool, our experimental setup offers the possibility to provide insight into the molecular mechanisms of bait-prey interaction. Recruitment of the EGFR together with Grb2 to clathrin coated pits (CCPs) was found to be a key feature in our assay. Application of bleaching experiments enabled calculation of the Grb2 exchange rate, which significantly changed upon stimulation or the presence of EGFR activity inhibiting drugs.

[1]  A. Sorkin,et al.  Live-cell fluorescence imaging reveals high stoichiometry of Grb2 binding to the EGF receptor sustained during endocytosis , 2014, Journal of Cell Science.

[2]  A. Bader,et al.  Endocytosis of EGFR requires its kinase activity and N-terminal transmembrane dimerization motif , 2013, Journal of Cell Science.

[3]  M. Brameshuber,et al.  Determination of binding curves via protein micropatterning in vitro and in living cells , 2013, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[4]  Qi Wu,et al.  Microplate-compatible total internal reflection fluorescence microscopy for receptor pharmacology. , 2013, Applied physics letters.

[5]  Y. Yarden,et al.  Inhibition of triple-negative breast cancer models by combinations of antibodies to EGFR , 2013, Proceedings of the National Academy of Sciences.

[6]  Jaroslaw Jacak,et al.  Identification of patterns in microscopy images of biological samples using evolution strategies , 2012 .

[7]  Ji Yu,et al.  Fast rebinding increases dwell time of Src homology 2 (SH2)-containing proteins near the plasma membrane , 2012, Proceedings of the National Academy of Sciences.

[8]  Kevin W Eliceiri,et al.  NIH Image to ImageJ: 25 years of image analysis , 2012, Nature Methods.

[9]  G. Schütz,et al.  VEGF-induced endothelial cell migration requires urokinase receptor (uPAR)-dependent integrin redistribution. , 2012, Cardiovascular research.

[10]  C. Antczak,et al.  Domain-based biosensor assay to screen for epidermal growth factor receptor modulators in live cells. , 2012, Assay and drug development technologies.

[11]  Hye-Nan Kim,et al.  Epidermal growth factor-stimulated human cervical cancer cell growth is associated with EGFR and cyclin D1 activation, independent of COX-2 expression levels. , 2012, International journal of oncology.

[12]  P. Harari,et al.  Understanding resistance to EGFR inhibitors—impact on future treatment strategies , 2010, Nature Reviews Clinical Oncology.

[13]  M. Brameshuber,et al.  Temporal resolution of protein–protein interactions in the live-cell plasma membrane , 2010, Analytical and bioanalytical chemistry.

[14]  Rainer Pepperkok,et al.  In situ analysis of tyrosine phosphorylation networks by FLIM on cell arrays , 2010, Nature Methods.

[15]  S. Gygi,et al.  Multiple mechanisms collectively regulate clathrin-mediated endocytosis of the epidermal growth factor receptor , 2010, The Journal of cell biology.

[16]  S. Swanson,et al.  Multiplexed Evaluation of a Cell-Based Assay for the Detection of Antidrug Neutralizing Antibodies to Panitumumab in Human Serum Using Automated Fluorescent Microscopy , 2010, Journal of biomolecular screening.

[17]  M. Brameshuber,et al.  In-vivo Detection of Protein-protein Interactions on Micro-patterned Surfaces , 2010, Journal of visualized experiments : JoVE.

[18]  D. Lauffenburger,et al.  Systems Analysis of EGF Receptor Signaling Dynamics with Micro-Western Arrays , 2010, Nature Methods.

[19]  Gerhard J Schütz,et al.  Detection of protein-protein interactions in the live cell plasma membrane by quantifying prey redistribution upon bait micropatterning. , 2010, Methods in enzymology.

[20]  Xavier Duval,et al.  Growth factor receptor expression in anal squamous lesions: modifications associated with oncogenic human papillomavirus and human immunodeficiency virus. , 2009, Human pathology.

[21]  C. Enrich,et al.  Annexins--modulators of EGF receptor signalling and trafficking. , 2009, Cellular signalling.

[22]  Gerhard J Schütz,et al.  Micropatterning for quantitative analysis of protein-protein interactions in living cells , 2008, Nature Methods.

[23]  P. P. Di Fiore,et al.  Clathrin-mediated internalization is essential for sustained EGFR signaling but dispensable for degradation. , 2008, Developmental cell.

[24]  L. Sequist,et al.  EGFR tyrosine kinase inhibitors in lung cancer: an evolving story. , 2008, Annual review of medicine.

[25]  A. Sorkin,et al.  Endocytosis and intracellular trafficking of ErbBs. , 2008, Experimental cell research.

[26]  Hiroaki Takagi,et al.  Multiple-state reactions between the epidermal growth factor receptor and Grb2 as observed by using single-molecule analysis , 2007, Proceedings of the National Academy of Sciences.

[27]  Qiang Wang,et al.  ErbB receptors: from oncogenes to targeted cancer therapies. , 2007, The Journal of clinical investigation.

[28]  S. Hubbard,et al.  Receptor tyrosine kinases: mechanisms of activation and signaling. , 2007, Current opinion in cell biology.

[29]  Erez M. Bublil,et al.  The EGF receptor family : spearheading a merger of signaling and therapeutics , 2007 .

[30]  M. McNiven,et al.  A novel endocytic mechanism of epidermal growth factor receptor sequestration and internalization. , 2006, Cancer research.

[31]  N. Normanno,et al.  Epidermal growth factor receptor (EGFR) signaling in cancer. , 2006, Gene.

[32]  H. Lane,et al.  ERBB Receptors and Cancer: The Complexity of Targeted Inhibitors , 2005, Nature Reviews Cancer.

[33]  M. Mann,et al.  Phosphotyrosine interactome of the ErbB-receptor kinase family , 2005, Molecular systems biology.

[34]  D. Rouillard,et al.  Additive interaction of gefitinib (‘Iressa’, ZD1839) and ionising radiation in human tumour cells in vitro , 2004, British Journal of Cancer.

[35]  D. M. Olive,et al.  Quantitative methods for the analysis of protein phosphorylation in drug development , 2004, Expert review of proteomics.

[36]  Patricia L. Harris,et al.  Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. , 2004, The New England journal of medicine.

[37]  J. Grandis,et al.  Pharmacokinetic and pharmacodynamic properties of EGFR inhibitors under clinical investigation. , 2004, Cancer treatment reviews.

[38]  Xuejun Jiang,et al.  Grb2 regulates internalization of EGF receptors through clathrin-coated pits. , 2003, Molecular biology of the cell.

[39]  Edouard C. Nice,et al.  Crystal Structure of a Truncated Epidermal Growth Factor Receptor Extracellular Domain Bound to Transforming Growth Factor α , 2002, Cell.

[40]  C. Arteaga Epidermal growth factor receptor dependence in human tumors: more than just expression? , 2002, The oncologist.

[41]  A. Sorkin,et al.  Effect of Tyrosine Kinase Inhibitors on Clathrin-coated Pit Recruitment and Internalization of Epidermal Growth Factor Receptor* , 2002, The Journal of Biological Chemistry.

[42]  J. Lippincott-Schwartz,et al.  Role of Grb2 in EGF-stimulated EGFR internalization. , 2002, Journal of cell science.

[43]  D. Bigner,et al.  EGF mutant receptor vIII as a molecular target in cancer therapy. , 2001, Endocrine-related cancer.

[44]  N. Normanno,et al.  Epidermal growth factor-related peptides and their receptors in human malignancies. , 1995, Critical reviews in oncology/hematology.

[45]  J. Schlessinger,et al.  Hierarchy of binding sites for Grb2 and Shc on the epidermal growth factor receptor , 1994, Molecular and cellular biology.

[46]  A. Ullrich,et al.  The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling , 1992, Cell.